Fresenius SE & Co. KGaA
Provides biopharma, medtech, and care services for critically and chronically ill patients.
FRE | F
Overview
Corporate Details
- ISIN(s):
- CH1298665980 (+4 more)
- LEI:
- XDFJ0CYCOO1FXRFTQS51
- Country:
- Germany
- Address:
- Else-Kröner-Straße 1, 61352 Bad Homburg vor der Höhe
- Website:
- https://www.fresenius.com/
- Sector:
- Human health and social work activities
- Industry:
- Hospital activities
Description
Fresenius SE & Co. KGaA is a global healthcare company focused on providing system-critical products and services for the treatment of critically and chronically ill patients. The group's primary operating companies are Fresenius Kabi and Fresenius Helios. Fresenius Kabi offers a portfolio of biopharmaceuticals, clinical nutrition, medical technologies, and intravenous generic drugs. Fresenius Helios is a leading private operator of hospitals and outpatient care facilities in Europe. The company also holds a significant investment in Fresenius Medical Care, a global leader in dialysis products and services. Through its '#FutureFresenius' strategic framework, the company is focused on strengthening its core business platforms in (Bio)Pharma, MedTech, and Care Provision to drive sustainable growth and innovation in patient care.
This is a Fraction of the Available Data.
You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Fresenius SE & Co. KGaA and 9,000+ other companies.
Stop analyzing yesterday's news. Start building a real-time advantage.
Request Enterprise API AccessFilings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-08-06 00:00 |
Interim Report
Half-yearly financial report 2025
|
English | 719.4 KB | |
| 2025-07-04 08:03 |
Declaration of Voting Results & Voting Rights Announcements
|
English | 77.9 KB | |
| 2025-06-20 11:34 |
Declaration of Voting Results & Voting Rights Announcements
|
German | 16.2 KB | |
| 2025-05-07 00:00 |
Quarterly Report
Q1 statement / Q1 financial report 2025
|
English | 1.4 MB | |
| 2025-04-24 00:00 |
Annual Report
Annual financial report 2024
|
English | 11.6 MB | |
| 2025-04-17 00:00 |
Governance Information
Corporate Governance Declaration and Report 2024 of Fresenius SE & Co. KGaA
|
English | 618.6 KB | |
| 2025-04-09 15:05 |
Pre-Annual General Meeting Information
Fresenius SE & Co. KGaA: Announcement of the Convening of the General Meeting …
|
English | 3.6 KB | |
| 2025-04-02 14:40 |
Director's Dealing
Fresenius SE & Co. KGaA: Robert Moller, buy
|
English | 6.5 KB | |
| 2025-04-01 16:16 |
Declaration of Voting Results & Voting Rights Announcements
|
English | 16.1 KB | |
| 2025-04-01 14:22 |
Director's Dealing
Fresenius SE & Co. KGaA: Sara Hennicken, buy
|
English | 6.5 KB | |
| 2025-03-24 16:09 |
Declaration of Voting Results & Voting Rights Announcements
|
English | 72.3 KB | |
| 2025-03-21 18:10 |
Major Shareholding Notification
|
English | 72.3 KB | |
| 2025-03-06 18:55 |
Declaration of Voting Results & Voting Rights Announcements
|
English | 72.4 KB | |
| 2025-03-04 18:03 |
M&A Activity
Fresenius SE & Co. KGaA: Fresenius announces its intention to reduce its stake …
|
English | 18.0 KB | |
| 2025-03-03 18:03 |
Major Shareholding Notification
Fresenius SE & Co. KGaA: Fresenius announces its intention to reduce its stake …
|
English | 18.0 KB |
Automate Your Workflow. Get a real-time feed of all Fresenius SE & Co. KGaA filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Fresenius SE & Co. KGaA via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2023-08-04 | Moser, Dr. Michael | Board | Buy | None | 300,565.98 EUR |
| 2023-04-03 | Sen, Michael | Board | Buy | None | 586,989.25 EUR |
| 2023-04-03 | Hennicken, Sara | Board | Buy | None | 49,839.92 EUR |
| 2022-11-18 | De Meo, Dr. Francesco | Board | Buy | None | 50,415.29 EUR |
| 2022-08-29 | De Meo, Dr. Francesco | Board | Sell | None | 50,831.20 EUR |
| 2022-08-05 | Sturm, Stephan | Board | Buy | None | 119,831.44 EUR |
| 2022-08-05 | Sturm, Stephan | Board | Buy | None | 119,676.59 EUR |
| 2022-08-05 | Schmitt, Martin | Board | Buy | None | 5,150.00 EUR |
| 2022-06-10 | Sturm, Stephan | Board | Other | None | 54,089.64 EUR |
| 2022-06-10 | Kirsch, Wolfgang | Supervisory board | Other | None | 6,901.09 EUR |
